Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals

In March 2020, the World Health Organization (WHO) declared a global health emergency—the coronavirus disease 2019 (COVID-19) pandemic. Since then, the development and implementation of vaccines against the virus amidst emerging cases of re-infection has prompted researchers to work towards understa...

Descripción completa

Detalles Bibliográficos
Autores principales: Casian, Joseph G., Angel, Aaron N., Lopez, Ronell, Bagos, Cedie, MacMullan, Melanie A., Bui, Mindy L., Chellamathu, Prithivi, Das, Sudipta, Turner, Fred, Slepnev, Vladimir, Ibrayeva, Albina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446671/
https://www.ncbi.nlm.nih.gov/pubmed/34539632
http://dx.doi.org/10.3389/fimmu.2021.701411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446671/
https://www.ncbi.nlm.nih.gov/pubmed/34539632
http://dx.doi.org/10.3389/fimmu.2021.701411

Ejemplares similares